InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Evans Carl Anthony, 董事. Officer active across 1 company, notably CNS Pharmaceuticals, Inc.. Aggregated, 2 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €9k. History available since 8 March 2022. The latest transaction was disclosed on 1 February 2024 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Carl Anthony Evans is a Board Member at CNS Pharmaceuticals, Inc. He contributes to the company's governance by bringing his expertise and experience to the board. Carl plays an active role in discussions on policies and key decisions that affect CNS Pharmaceuticals' future. His commitment to corporate responsibility and transparency is essential for maintaining shareholder and stakeholder trust. As a Board Member, he participates in evaluating the company's performance and initiatives.